Universal Ibogaine Inc. CEO’s ecstatic to work with Blue Digital
"We are happy to have access to Blue Digital's distribution channels, as their range across borders will broaden awareness of our business to new audiences," said Nick Karos, UI's Chief Executive Officer. Because addiction knows no bounds, the remedy we seek must be global in scope." As Blue Digital Media professional radar.
Microcap
$HMTXF going up in flash on the OTC
$HMTXF today marked quite an impressive opening in the otc market and is currently trading with a steady pace at $0.1960 with a notable spike
Hemostemix hires new financial advisor to the family
Mr. Rick Groome who has effectively settled 2 securities firm, helping many successful biotechnology companies in providing funds over the last three decades has joined hemostemix as a special financial advisor.
$IBO’S CEO comments on the H.C Wainwright
"H.C. Wainwright is a leader in the field and may be a significant strategic partner in our ongoing corporate finance roadmap," said Nick Karos, CEO of Universal Ibogaine. Another crucial step in raising awareness of our brand and service is the chance to share our story with this audience.
$HEM recoups legal guardianship of its lost intellectual The company has legally retrieved all intellectual data related to stage 2 clinical trial data, along with all previous data from Hemostemix Israel and the randomized table needed to evaluate ACP-01 clinical trial data in North America and South Africa.
Nick Karos excited by listing of UI on Frankfurt stock exchange Universal Ibogaine Inc. CEO made a statement "Our capital markets and investor relations strategy includes the FSE listing. We recently began trading on the OTCQB Exchange in the United States, and curiosity in the UI story is growing in Europe, particularly Germany. With a mushrooming market and interest in psychedelic medications, Germany has a reputation for innovation and leadership."
Skrumble Network BreakoutThis crypto has broken out with good volumes and Retested in daily candlestick chart, and may rally further. It is a small cap, so this trade is of high risk and due caution is advised.
Risk Reward Ratio - 2:1
SL placed below 200 EMA & Target near ATH.
DYOR.
Vikram Thermo- A bottom fishingVikram Thermo a microcap company is currently taking support and has a triangle formation in its chart. A buy can be considered now or after breaking the trendline.
The RSI is also looking for a breakout.
Risk-Reward Ratio is on the lower side with this setup. Strict SL at closing below 187 .
WELSPUNIND, 1D, Good for short term positionalWelspunind, has given a breakout on a daily as well as a weekly chart.
All levels are marked on the chart itself.
Looks good for short-term Positional.
PS: All analyses are for educational purposes only.